Context Therapeutics Q3 EPS $(0.08) Beats $(0.11) Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings Beats
Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.11) by 27.27 percent. This is a 20 percent increase over losses of $(0.10) per share
Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.11) by 27.27 percent. This is a 20 percent increase over losses of $(0.10) per share from the same period last year.